BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 4573354)

  • 1. The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids.
    Jordon RE; Day NK; Sams WM; Good RA
    J Clin Invest; 1973 May; 52(5):1207-14. PubMed ID: 4573354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
    Jordon RE; Nordby JM; Milstein H
    J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotactic activity in the fluid of bullous pemphigoid blisters].
    Diáz Pérez JL; Jordon RE
    Med Cutan Ibero Lat Am; 1975; 3(6):465-70. PubMed ID: 778510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and blister fluid anticomplementary activity in pemphigus and bullous pemphigoid. Sucrose density gradient studies.
    Jordon RE; McDuffie FC
    Proc Soc Exp Biol Med; 1976 Mar; 151(3):594-8. PubMed ID: 768993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An eosinophil chemotactic factor present in blister fluids of bullous pemphigoid patients.
    Baba T; Sonozaki H; Seki K; Uchiyama M; Ikesawa Y; Toriisu M
    J Immunol; 1976 Jan; 116(1):112-6. PubMed ID: 1107422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement in pemphigus vulgaris and other bullous dermatoses.
    Sbano E; Auteri A; Fimiani M; Volpi L
    Arch Dermatol Res (1975); 1975 Dec; 254(2):143-8. PubMed ID: 56159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of antibody titers of blister fluid and serum in patients with subepidermal immunobullous diseases.
    Daneshpazhooh M; Shahdi M; Aghaeepoor M; Hasiri G; Chams C
    Int J Dermatol; 2004 May; 43(5):348-51. PubMed ID: 15117364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid.
    Provost TT; Tomasi TB
    J Clin Invest; 1973 Jul; 52(7):1779-87. PubMed ID: 4352464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bullous pemphigoid: interaction of interleukin 5, anti-basement membrane zone antibodies and eosinophils. A preliminary observation.
    Engineer L; Bhol K; Kumari S; Razzaque Ahmed A
    Cytokine; 2001 Jan; 13(1):32-38. PubMed ID: 11145840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation in bullous skin diseases.
    Jordon RE
    J Invest Dermatol; 1975 Jul; 65(1):162-9. PubMed ID: 50385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.
    Bhol KC; Rojas AI; Khan IU; Ahmed AR
    Cytokine; 2000 Jul; 12(7):1076-83. PubMed ID: 10880254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of bullous pemphigoid with antibodies against intercellular 130 kd antigen.
    Takahashi H; Wada T; Matsuo S; Iwatsuki K; Iizuka H
    J Dermatol; 1995 Aug; 22(8):576-81. PubMed ID: 7560455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predominance of IgG4 in prodromal bullous pemphigoid.
    Lamb PM; Patton T; Deng JS
    Int J Dermatol; 2008 Feb; 47(2):150-3. PubMed ID: 18211485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
    Ishikawa O; Zaw KK; Miyachi Y; Hashimoto T; Tanaka T
    Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor.
    Jordon RE; Struve MF; Bushkell LL
    Clin Exp Immunol; 1981 Jul; 45(1):29-36. PubMed ID: 7030538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blister fluid for the diagnosis of subepidermal immunobullous diseases: a comparative study of basement membrane zone autoantibodies detected in blister fluid and serum.
    Zhou S; Wakelin SH; Allen J; Wojnarowska F
    Br J Dermatol; 1998 Jul; 139(1):27-32. PubMed ID: 9764145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes gestationis. Immunopathology and characterization of the HG factor.
    Katz SI; Hertz KC; Yaoita H
    J Clin Invest; 1976 Jun; 57(6):1434-41. PubMed ID: 819458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin G subclass distribution of bullous pemphigoid autoantibodies and complement fixation studies.
    Al-Karawi KS
    Saudi Med J; 2002 Dec; 23(12):1492-5. PubMed ID: 12518199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation in pemphigus vulgaris blister fluid.
    Jordan RE; Day NK; Luckasen JR; Good RA
    Clin Exp Immunol; 1973 Sep; 15(1):53-63. PubMed ID: 4765721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component.
    Chan LS; Cooper KD
    Arch Dermatol; 1994 Mar; 130(3):343-7. PubMed ID: 8129413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.